297 related articles for article (PubMed ID: 10571690)
1. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.
Nishi Y; Atley L; Eyre DE; Edelson JG; Superti-Furga A; Yasuda T; Desnick RJ; Gelb BD
J Bone Miner Res; 1999 Nov; 14(11):1902-8. PubMed ID: 10571690
[TBL] [Abstract][Full Text] [Related]
2. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
[TBL] [Abstract][Full Text] [Related]
3. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
Katagiri M; Fukunaga M; Ohtawa T; Harada T
World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
[TBL] [Abstract][Full Text] [Related]
4. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
[TBL] [Abstract][Full Text] [Related]
5. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Pons F; Martínez de Osaba MJ; Echevarría M; Ballesta AM; Muñoz-Gómez J
Bone; 1999 Sep; 25(3):349-53. PubMed ID: 10495139
[TBL] [Abstract][Full Text] [Related]
6. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
Rauchenzauner M; Schmid A; Heinz-Erian P; Kapelari K; Falkensammer G; Griesmacher A; Finkenstedt G; Högler W
J Clin Endocrinol Metab; 2007 Feb; 92(2):443-9. PubMed ID: 17105843
[TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of bone turnover markers with the treatment of osteoporosis].
Miura M
Clin Calcium; 2014 Mar; 24(3):367-76. PubMed ID: 24576933
[TBL] [Abstract][Full Text] [Related]
8. Circulating biochemical markers of bone remodeling in uremic patients.
Ureña P; De Vernejoul MC
Kidney Int; 1999 Jun; 55(6):2141-56. PubMed ID: 10354264
[TBL] [Abstract][Full Text] [Related]
9. Erosive arthritis in a patient with pycnodysostosis: an experiment of nature.
Ainola M; Valleala H; Nykänen P; Risteli J; Hanemaaijer R; Konttinen YT
Arthritis Rheum; 2008 Nov; 58(11):3394-401. PubMed ID: 18975331
[TBL] [Abstract][Full Text] [Related]
10. New and traditional serum markers of bone metabolism in the detection of skeletal metastases.
Plebani M; Bernardi D; Zaninotto M; De Paoli M; Secchiero S; Sciacovelli L
Clin Biochem; 1996 Feb; 29(1):67-72. PubMed ID: 8929827
[TBL] [Abstract][Full Text] [Related]
11. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
12. [Prediction by early change of bone metabolic markers of the efficacy of anti-osteoporotic drugs on bone mass in osteoporotic patients].
Inaba M
Clin Calcium; 2014 Mar; 24(3):379-84. PubMed ID: 24576934
[TBL] [Abstract][Full Text] [Related]
13. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
[TBL] [Abstract][Full Text] [Related]
14. Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating by cross-linked N-telopeptide neoepitope.
Atley LM; Mort JS; Lalumiere M; Eyre DR
Bone; 2000 Mar; 26(3):241-7. PubMed ID: 10709996
[TBL] [Abstract][Full Text] [Related]
15. Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens.
Vejlgaard T; Abildgaard N; Jans H; Nielsen JL; Heickendorff L
Eur J Haematol; 1997 Feb; 58(2):104-8. PubMed ID: 9111591
[TBL] [Abstract][Full Text] [Related]
16. Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis.
Fratzl-Zelman N; Valenta A; Roschger P; Nader A; Gelb BD; Fratzl P; Klaushofer K
J Clin Endocrinol Metab; 2004 Apr; 89(4):1538-47. PubMed ID: 15070910
[TBL] [Abstract][Full Text] [Related]
17. Biochemical markers of bone turnover in Camurati-Engelmann disease: a report on four cases in one family.
Hernández MV; Peris P; Guañabens N; Alvarez L; Monegal A; Pons F; Ponce A; Muñoz-Gómez J
Calcif Tissue Int; 1997 Jul; 61(1):48-51. PubMed ID: 9192513
[TBL] [Abstract][Full Text] [Related]
18. Running has a negative effect on bone metabolism and proinflammatory status in male aged rats.
Sipos W; Rauner M; Skalicky M; Viidik A; Hofbauer G; Schett G; Redlich K; Lang S; Pietschmann P
Exp Gerontol; 2008 Jun; 43(6):578-83. PubMed ID: 18442888
[TBL] [Abstract][Full Text] [Related]
19. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.
Garnero P; Ferreras M; Karsdal MA; Nicamhlaoibh R; Risteli J; Borel O; Qvist P; Delmas PD; Foged NT; Delaissé JM
J Bone Miner Res; 2003 May; 18(5):859-67. PubMed ID: 12733725
[TBL] [Abstract][Full Text] [Related]
20. Pycnodysostosis: role and regulation of cathepsin K in osteoclast function and human disease.
Motyckova G; Fisher DE
Curr Mol Med; 2002 Aug; 2(5):407-21. PubMed ID: 12125807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
